SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-14-001275
Filing Date
2014-03-19
Accepted
2014-03-19 16:38:17
Documents
14
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT sbfm_10k.htm 10-K 1912319
2 CERTIFICATION sbfm_ex311.htm EX-31.1 16964
3 CERTIFICATION sbfm_ex312.htm EX-31.2 16726
4 CERTIFICATION sbfm_ex32.htm EX-32 11049
5 img001.jpg GRAPHIC 18104
6 img002.jpg GRAPHIC 25746
7 img003.jpg GRAPHIC 33475
8 img004.jpg GRAPHIC 17452
  Complete submission text file 0001354488-14-001275.txt   3217757

Data Files

Seq Description Document Type Size
9 sbfm-20131231.xml EX-101.INS 121789
10 sbfm-20131231.xsd EX-101.SCH 20741
11 sbfm-20131231_cal.xml EX-101.CAL 22727
12 sbfm-20131231_lab.xml EX-101.LAB 141071
13 sbfm-20131231_pre.xml EX-101.PRE 81394
14 sbfm-20131231_def.xml EX-101.DEF 33314
Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4
Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52898 | Film No.: 14704360
SIC: 8742 Services-Management Consulting Services
Office of Trade & Services